Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2011, Article ID 680902, 6 pages
http://dx.doi.org/10.1155/2011/680902
Research Article

Application of Certain π-Acceptors for the Spectrophotometric Determination of Alendronate Sodium in Pharmaceutical Bulk and Dosage Forms

1Analytical Laboratory, Bio Fine Pharmaceuticals, 74 Industrial Estate, Multan 60900, Pakistan
2Department of Pharmacognosy, Research Institute of Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan

Received 11 January 2011; Revised 1 May 2011; Accepted 1 May 2011

Academic Editor: Mohamed Abdel-Rehim

Copyright © 2011 Asad Raza and Muhammad Zia-ul-Haq. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Seam, The Complete Drug Reference, Pharmaceutical Press, London, Uk, 2002.
  2. K. J. Edwin, Goodman and Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, New York, NY, USA, 10th edition, 2001.
  3. Y. K. Zhang, S. Y. Fan, L. E. He, J. L. Ma, and C. Y. Qi, “Determination of sodium alendronate tablets by spectrophotometry,” Fenxi Huaxue, vol. 28, no. 9, p. 1181, 2001. View at Google Scholar · View at Scopus
  4. S. N. Meyya Nathan, G. V. S. Rama Sharma, V. Bhanuprakash Reddy, and B. Suresh, “Quantitative determination of alendronate sodium in pharmaceutical dosage forms and in bulk drug by spectrophotometry,” Indian Drugs, vol. 38, no. 9, pp. 462–463, 2001. View at Google Scholar · View at Scopus
  5. J. Kuljanin, I. Jankovic, J. Nedeljkovic, D. Prstojevic, and V. Marinkovic, “Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1215–1220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. E. A. Taha and N. F. Youssef, “Spectrophotometric determination of some drugs for osteoporosis,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 12, pp. 1444–1447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Kwong, A. M. Y. Chiu, S. A. McClintock, and M. L. Cotton, “HPLC analysis of an amino bisphosphonate in pharmaceutical formulations using postcolumn derivatization and fluorescence detection,” Journal of Chromatographic Science, vol. 28, no. 11, pp. 563–566, 1990. View at Google Scholar · View at Scopus
  8. E. W. Tsai, S. D. Chamberlin, R. J. Forsyth, C. Bell, D. P. Ip, and M. A. Brooks, “Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatogrraphy with indirect UV detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 12, no. 8, pp. 983–991, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. H. R. Han and X. Z. Qin, “Determination of alendronate sodium by ion chromatography with refractive index detection,” Journal of Chromatography A, vol. 719, no. 2, pp. 345–352, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. De Marco, S. E. Biffar, D. G. Reed, and M. A. Brooks, “The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 7, no. 12, pp. 1719–1727, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Ptacek, J. Klima, and J. Macek, “Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography,” Journal of Chromatography B, vol. 767, no. 1, pp. 111–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. W. F. Kline and B. K. Matuszewski, “Improved determination of the bisphosphonate alendronate in human plasma and urine by automated precolumn derivatization and high-performance liquid chromatography with fluorescence and electrochemical detection,” Journal of Chromatography—Biomedical Applications, vol. 583, no. 2, pp. 183–193, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. European Pharmacopoeia, Council of Europe, Strasbourg, France, 3rd edition, 2001.
  14. E. W. Tsai, M. M. Singh, H. H. Lu, D. P. Ip, and M. A. Brooks, “Application of capillary electrophoresis to pharmaceutical analysis: determination of alendronate in dosage forms,” Journal of Chromatography, vol. 626, no. 2, pp. 245–250, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Reed, G. P. Martin, J. M. Konieczny, and M. A. Brooks, “The determination of alendronate sodium in tablets by inductively coupled plasma (ICP),” Journal of Pharmaceutical and Biomedical Analysis, vol. 13, no. 8, pp. 1055–1058, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. O. A. Razak, S. F. Belal, M. M. Bedair, and R. S. Haggag, “The utilization of copper(II) phosphate for the anodic stripping voltammetric assay of alendronate sodium, desferrioxamine mesylate and lisinopril,” Talanta, vol. 59, no. 5, pp. 1061–1069, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. Raza, “Utility of certain π-Acceptors for the spectrophotometric determination of tranexamic acid in commercial dosage forms,” Analytical Letters, vol. 39, no. 10, pp. 2217–2226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Rahman, N. A. Khan, and S. N. H. Azmi, “Validated spectrophotometric methods for the determination of amiodarone hydrochloride in commercial dosage forms using p-chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone,” Analytical Sciences, vol. 20, no. 8, pp. 1231–1235, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Al-Ghannam, “New spectrophotometric methods for microdetermination of fluoxacillin and cloxacillin in pure and dosage forms,” Mikrochimica Acta, vol. 138, no. 1-2, pp. 29–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. M. Issa, F. M. Abou-Attia, F. M. Abdel-Gawad, and S. M. Abdel-Hamid, “Utility of some Pi-Acceptors for the spectrophotometric determination of trimetazidine hydrochloride,” Analytical Letters, vol. 35, no. 3, pp. 451–461, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Gorog, Ultraviolet-Visible Spectrophotometry in Pharmaceutical Analysis, CRC Press, Boca Raton, Fla, USA, 1995.
  22. R. Foster, Organic Charge-Transfer Complexes, Academic Press, London, New York, USA, 1969.
  23. British Pharmacopoeia, HM Stationery Office, London, UK, 2005.
  24. G. D. Christian, Analytical Chemistry, John Wiley & Sons, Singapore, 4th edition, 1994.